Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markman

Showing results (161-170 of 1,622) with videos related to

Pageof 163
Sort By:
Journal of Cancer Research and Clinical Oncology|January 1, 1995
Chemosensitivity and chemoresistance assays: are they clinically relevant?M Markman
Seminars in Oncology|April 1, 1995
Surgery for support and palliation in patients with malignant diseaseM Markman
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1993
Supportive careM Markman
Seminars in Oncology|June 1, 1995
Rationale for examining the combination of paclitaxel and ifosfamide in the treatment of advanced ovarian cancerM Markman
Journal of Cancer Research and Clinical Oncology|January 1, 1993
Report from the 34th annual meeting of the American Society of Hematology, December 4-8, 1992M Markman
Journal of Cancer Research and Clinical Oncology|January 1, 1993
Second-look laparotomies in ovarian cancer: a medical oncologist's perspectiveM Markman
Journal of Cancer Research and Clinical Oncology|January 1, 1996
Regional chemotherapy: revisitedM Markman
Cleveland Clinic Journal of Medicine|May 1, 1993
Surgeon's skill key to ovarian cancer managementM Markman
Current Oncology Reports|August 5, 2004
What is the clinically relevant endpoint for cancer prevention trials?Maurie Markman
The Journal of Supportive Oncology|September 9, 2004
Does palliative chemotherapy palliate?Maurie Markman
Pageof 163

Showing results (161-170 of 1,622) with videos related to

Sort By:
Pageof 163
Journal of Cancer Research and Clinical Oncology|January 1, 1995
Chemosensitivity and chemoresistance assays: are they clinically relevant?M Markman
Seminars in Oncology|April 1, 1995
Surgery for support and palliation in patients with malignant diseaseM Markman
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1993
Supportive careM Markman
Seminars in Oncology|June 1, 1995
Rationale for examining the combination of paclitaxel and ifosfamide in the treatment of advanced ovarian cancerM Markman
Journal of Cancer Research and Clinical Oncology|January 1, 1993
Report from the 34th annual meeting of the American Society of Hematology, December 4-8, 1992M Markman
Journal of Cancer Research and Clinical Oncology|January 1, 1993
Second-look laparotomies in ovarian cancer: a medical oncologist's perspectiveM Markman
Journal of Cancer Research and Clinical Oncology|January 1, 1996
Regional chemotherapy: revisitedM Markman
Cleveland Clinic Journal of Medicine|May 1, 1993
Surgeon's skill key to ovarian cancer managementM Markman
Current Oncology Reports|August 5, 2004
What is the clinically relevant endpoint for cancer prevention trials?Maurie Markman
The Journal of Supportive Oncology|September 9, 2004
Does palliative chemotherapy palliate?Maurie Markman
Pageof 163